COMMUNIQUÉS West-GlobeNewswire

Avricore Health Inc. Launches New Website
03/04/2019
With a focus on offering pharmagenomics and emerging health technologies, Avricore’s new website is a portal for pharmacy innovation. Vancouver, April 03, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“ [...]
EZClaim Partners with Alpha II to Offer ClaimStaker™ Clinical Claim and Encounter Scrubbing Solution
03/04/2019
Integration extends to more than 4,500 EZClaim customers to validate claims and improve clinical accuracy TALLAHASSEE, Fla. and ROCHESTER, Mich., April 03, 2019 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of [...]
AspireAssist® Receives Endorsement by the American Society of Metabolic and Bariatric Surgeons
03/04/2019
EXTON, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc. (“Aspire”), a commercial-stage medical device company, announced today that the American Society of the Metabolic and Bariatric Surgeons (“ASMBS”) [...]
New Features in Exa Mammo Designed to Address Quality Assurance and Improve Communication
03/04/2019
WAYNE, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., will highlight new features of Exa® Mammo, a PACS designed for breast imaging centers. Exa Mammo enables anywhere mammography [...]
Y-mAbs Therapeutics To Present At The H.C. Wainwright Global Life Sciences Conference in London
03/04/2019
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Vericel to Present at Needham Healthcare Conference
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Caladrius Biosciences to Participate in Upcoming Conferences
03/04/2019
BASKING RIDGE, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]
UPDATE -- PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis to the Projected $57 Billion Global Legal Cannabis Market
03/04/2019
SUNRISE, Fla., April 03, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce the signing of a letter of intent for the assignment of a temporary license to prepare farm located at [...]
Cannabis Traceability: Problems & Solutions -- CFN Media
03/04/2019
Seattle, WA, April 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
BriaCell's Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity
03/04/2019
As presented at the American Association for Cancer Research (AACR) annual meeting: early efficacy data for the first six advanced breast cancer patients dosed with Bria-IMT™ in combination with KEYTRUDA® suggest [...]
Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
03/04/2019
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Obalon Announces Restructuring to Streamline Operations & Cash Use
03/04/2019
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the 2019 American Association for Cancer Research (AACR) Annual Meeting
03/04/2019
Preclinical data supports the development of JTX-8064 as a novel immunotherapy to reprogram immune-suppressive macrophages and enhance anti-tumor immunity CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Jounce [...]
Evelo Biosciences to Present at 18th Annual Needham Healthcare Conference
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials, a potential new modality of oral biologic [...]
Soleno Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
03/04/2019
REDWOOD CITY, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
GBT Announces New Employment Inducement Grants
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on April 1, 2019, the compensation committee of GBT’s board of directors granted [...]
Kezar Life Sciences to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT002, Nasal Naltrexone, for Treatment of Alcohol Use Disorder
03/04/2019
Data published online in The Journal of Clinical Pharmacology SANTA MONICA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines [...]
Shockwave Completes Enrollment of Disrupt CAD II Study
03/04/2019
European Post-Market Study to Demonstrate Ongoing Safety of Coronary Intravascular Lithotripsy SANTA CLARA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development [...]

Pages